These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 10688401)

  • 1. Polycystic kidney disease: <<30 ans après>>.
    Grünfeld JP; Chauveau D; Joly D; Fonck C; Oualim Z
    J Nephrol; 1999; 12 Suppl 2():S42-6. PubMed ID: 10688401
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autosomal dominant polycystic kidney disease (ADPKD, MIM 173900, PKD1 and PKD2 genes, protein products known as polycystin-1 and polycystin-2).
    Boucher C; Sandford R
    Eur J Hum Genet; 2004 May; 12(5):347-54. PubMed ID: 14872199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inherited cystic diseases of the kidney.
    Choyke PL
    Radiol Clin North Am; 1996 Sep; 34(5):925-46. PubMed ID: 8784390
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lowering of Pkd1 expression is sufficient to cause polycystic kidney disease.
    Lantinga-van Leeuwen IS; Dauwerse JG; Baelde HJ; Leonhard WN; van de Wal A; Ward CJ; Verbeek S; Deruiter MC; Breuning MH; de Heer E; Peters DJ
    Hum Mol Genet; 2004 Dec; 13(24):3069-77. PubMed ID: 15496422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimal care of autosomal dominant polycystic kidney disease patients.
    Schrier RW
    Nephrology (Carlton); 2006 Apr; 11(2):124-30. PubMed ID: 16669974
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Variable progression of autosomal dominant polycystic kidney disease: genetic and molecular counterparts].
    Devuyst O
    Nephrol Ther; 2006 Jan; 2 Suppl 2():S104-8. PubMed ID: 17373208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Polycystic kidney diseases: molecular genetics and counselling].
    Lespinasse J; Fourcade J; Schir F
    Nephrol Ther; 2006 Jul; 2(3):120-6. PubMed ID: 16890136
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A truncated polycystin-2 protein causes polycystic kidney disease and retinal degeneration in transgenic rats.
    Gallagher AR; Hoffmann S; Brown N; Cedzich A; Meruvu S; Podlich D; Feng Y; Könecke V; de Vries U; Hammes HP; Gretz N; Witzgall R
    J Am Soc Nephrol; 2006 Oct; 17(10):2719-30. PubMed ID: 16943309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Variable renal disease progression in autosomal dominant polycystic kidney disease: a role for nitric oxide?
    Devuyst O
    J Nephrol; 2003; 16(3):449-52. PubMed ID: 12832751
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polycystic liver and kidney diseases.
    Tahvanainen E; Tahvanainen P; Kääriäinen H; Höckerstedt K
    Ann Med; 2005; 37(8):546-55. PubMed ID: 16338757
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical approach in polycystic kidney disease with recurrent hematuria].
    Tepel M
    Internist (Berl); 1997 Dec; 38(12):1239-41. PubMed ID: 9465332
    [No Abstract]   [Full Text] [Related]  

  • 12. Toxic tubular injury in kidneys from Pkd1-deletion mice accelerates cystogenesis accompanied by dysregulated planar cell polarity and canonical Wnt signaling pathways.
    Happé H; Leonhard WN; van der Wal A; van de Water B; Lantinga-van Leeuwen IS; Breuning MH; de Heer E; Peters DJ
    Hum Mol Genet; 2009 Jul; 18(14):2532-42. PubMed ID: 19401297
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pathogenesis of cystic kidney diseases].
    Walz G
    Verh Dtsch Ges Pathol; 2002; 86():138-44. PubMed ID: 12647363
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyst number but not the rate of cystic growth is associated with the mutated gene in autosomal dominant polycystic kidney disease.
    Harris PC; Bae KT; Rossetti S; Torres VE; Grantham JJ; Chapman AB; Guay-Woodford LM; King BF; Wetzel LH; Baumgarten DA; Kenney PJ; Consugar M; Klahr S; Bennett WM; Meyers CM; Zhang QJ; Thompson PA; Zhu F; Miller JP
    J Am Soc Nephrol; 2006 Nov; 17(11):3013-9. PubMed ID: 17035604
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiovascular polycystins: insights from autosomal dominant polycystic kidney disease and transgenic animal models.
    Bichet D; Peters D; Patel AJ; Delmas P; Honoré E
    Trends Cardiovasc Med; 2006 Nov; 16(8):292-8. PubMed ID: 17055386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased activity of activator protein-1 transcription factor components ATF2, c-Jun, and c-Fos in human and mouse autosomal dominant polycystic kidney disease.
    Le NH; van der Wal A; van der Bent P; Lantinga-van Leeuwen IS; Breuning MH; van Dam H; de Heer E; Peters DJ
    J Am Soc Nephrol; 2005 Sep; 16(9):2724-31. PubMed ID: 16049073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of polycystin-1 in human cyst-lining epithelia leads to ciliary dysfunction.
    Nauli SM; Rossetti S; Kolb RJ; Alenghat FJ; Consugar MB; Harris PC; Ingber DE; Loghman-Adham M; Zhou J
    J Am Soc Nephrol; 2006 Apr; 17(4):1015-25. PubMed ID: 16565258
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New advances in evaluation and management of patients with polycystic liver disease.
    Arnold HL; Harrison SA
    Am J Gastroenterol; 2005 Nov; 100(11):2569-82. PubMed ID: 16279915
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pax2 gene dosage influences cystogenesis in autosomal dominant polycystic kidney disease.
    Stayner C; Iglesias DM; Goodyer PR; Ellis L; Germino G; Zhou J; Eccles MR
    Hum Mol Genet; 2006 Dec; 15(24):3520-8. PubMed ID: 17082250
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intracranial aneurysms and autosomal dominant polycystic kidney disease: followup study by magnetic resonance angiography.
    Nakajima F; Shibahara N; Arai M; Gohji K; Ueda H; Katsuoka Y
    J Urol; 2000 Aug; 164(2):311-3. PubMed ID: 10893572
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.